Maryline Dekermandjian

Maryline DEKERMANDJIAN is an experienced professional in the pharmaceutical and healthcare sectors, currently serving as the Oncology Business Unit Director at Ipsen since March 2023. Previously, Maryline held various leadership roles at UCB from January 2021 to March 2023, including Neurology and Rare Diseases Business Unit Director and Chief of Staff to the Global Core Leadership Team in Immunology. Maryline also worked as the Marketing and Clinical Director for Diabetes Care at BD from February 2019 to December 2020, and as the Digital and Sales Transformation Lead for the Diabetes Business Unit at MSD France from June 2016 to February 2019. Additional experience includes senior positions at Servier and consulting roles at AEC Partners and Arthur D. Little. Maryline DEKERMANDJIAN holds a Doctorate in Pharmacy from Université Claude Bernard Lyon 1 and a Master of Science in Strategic Management from HEC Paris.